This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Yao Wang: Innovator in Melanocortin-4 Receptor Agonist Activity
Introduction
Yao Wang is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of selective cyclic peptides. His work focuses on addressing obesity through innovative peptide design.
Latest Patents
Yao Wang holds a patent for "Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity." This patent describes peptides that are cyclized via disulfide or lactam bridges. These peptides exhibit melanocortin-4 receptor agonist activity, making them useful for treating obesity. He has 1 patent to his name.
Career Highlights
Yao Wang is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves research and development in the area of peptide therapeutics. His innovative approach has positioned him as a key player in the fight against obesity.
Collaborations
Yao Wang has collaborated with talented coworkers such as Xin-Jie Chu and Adrian Wai-Hing Cheung. Their combined expertise enhances the research efforts at Hoffmann-La Roche Inc.
Conclusion
Yao Wang's contributions to the field of peptide research are noteworthy, particularly in the context of obesity treatment. His innovative work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile